QUESTLAB
QUESTLAB financials
- Market cap
- ₹126 Cr
- Sector
- Healthcare
Quarterly results
Q4 FY26: revenue down 30.2%, net profit up 47.9% against the same quarter last year.
| Line item | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15 | 27 | 15 | 46 | 23 +52% | 26 −6% | 31 +106% | 32 −30% |
| EBITDA | 2 | 9 | 1 | 1 | 4 +115% | 3 −62% | 7 +947% | 4 +411% |
| Net profit | 1 | 6 | 1 | 2 | 4 +177% | 4 −34% | 4 +417% | 3 +48% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −19.6% 1Y
1Y: ₹97 on 15 Sept 2025 → ₹78. High ₹151.65 (30 Apr 2026), low ₹77 (15 Sept 2026).
Financials, as filed
Revenue grew 7.6% a year over 1 year, FY25 to FY26. Operating margin widened to 16.3%.
| Year ending | FY25 | FY26 |
|---|---|---|
| Revenue | ₹104 Cr | ₹112 Cr |
| Operating profit | ₹12 Cr | ₹18 Cr |
| Operating margin | 11.6% | 16.3% |
| Interest | ₹1 Cr | ₹2 Cr |
| Depreciation | ₹1 Cr | ₹1 Cr |
| Net profit | ₹10 Cr | ₹15 Cr |
| Net margin | 9.9% | 13.4% |
| ROCE | 27.0% | 18.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹12 Cr | ₹16 Cr | ₹16 Cr |
| Reserves | ₹5 Cr | ₹9 Cr | ₹14 Cr | ₹17 Cr | ₹65 Cr | ₹80 Cr |
| Borrowings | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹30 Cr | ₹8 Cr |
| Other liabilities | ₹9 Cr | ₹22 Cr | ₹28 Cr | ₹27 Cr | ₹10 Cr | ₹6 Cr |
| Total liabilities | ₹18 Cr | ₹35 Cr | ₹47 Cr | ₹61 Cr | ₹122 Cr | ₹111 Cr |
| Fixed assets | ₹6 Cr | ₹7 Cr | ₹10 Cr | ₹10 Cr | ₹12 Cr | ₹15 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹7 Cr | ₹52 Cr | ₹16 Cr |
| Other assets | ₹12 Cr | ₹27 Cr | ₹37 Cr | ₹44 Cr | ₹58 Cr | ₹79 Cr |
| Total assets | ₹18 Cr | ₹35 Cr | ₹47 Cr | ₹61 Cr | ₹122 Cr | ₹111 Cr |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
Since Mar 2025, promoters added +0.57 pp while FIIs trimmed −0.34 pp. The shareholder count shrank 9% to 911.
- Promoters
- 66.8%
- FIIs
- 0.6%
- DIIs
- 2.0%
- Public
- 30.6%
Since Mar 2025
- Promoters +0.57 pp
- FIIs −0.34 pp
- Public −0.21 pp
How it drifted, 6 quarters
Over this window DIIs fell from 4.4% to 2.0% — −2.4 pp.
Ownership split by quarter, oldest first. Sep '24: Promoters 65.8%, FIIs 0.7%, DIIs 4.4%, Public 29.0%.Dec '24: Promoters 65.8%, FIIs 1.3%, DIIs 4.9%, Public 28.0%.Mar '25: Promoters 66.2%, FIIs 0.9%, DIIs 2.1%, Public 30.8%.Sep '25: Promoters 66.8%, FIIs 0.9%, DIIs 1.4%, Public 30.9%.Dec '25: Promoters 66.8%, FIIs 0.6%, DIIs 1.4%, Public 31.2%.Mar '26: Promoters 66.8%, FIIs 0.6%, DIIs 2.0%, Public 30.6%.
Who bought this quarter
since Dec 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Yashvi Hitesh Patel newly disclosed 3.41% held
- Harsha Venkatesh newly disclosed 2.35% held
- Dimple Kothari newly disclosed 1.60% held
- Sunil Kumar Chhabra newly disclosed 1.08% held
- Sandeep Kothari newly disclosed 1.06% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of QUESTLAB above SEBI's 1% disclosure line, and what changed since Dec 2025.
| Holder | Stake | Change |
|---|---|---|
| Anil Kumar Sabarwal | 62.80% | unchanged |
| Yashvi Hitesh Patel | 3.41% | newly disclosed |
| Tejaswini Sabarwal | 2.59% | unchanged |
| Harsha Venkatesh | 2.35% | newly disclosed |
| Dimple Kothari | 1.60% | newly disclosed |
| Vinayak Sabarwal | 1.40% | unchanged |
| Sunil Kumar Chhabra | 1.08% | newly disclosed |
| Sandeep Kothari | 1.06% | newly disclosed |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
AttractiveTo justify its price of ₹78, this stock must grow earnings at -3% every year for 7 years. Our analysis caps realistic growth at ~101%. At that growth it is worth ₹7743 — upside of 9826%.
- Growth the price implies
- -2.6% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 100.9% a year
- net profit, FY25–FY26 · EPS 100.6%
- The gap
- -1.0 pp
- 9826% downside if it only repeats history
Learn to analyse QUESTLAB
Guides on how to read this kind of business and the numbers that matter.